Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhEPO and retinopathy of prematurity randomized trial
ChiCTR2100042351Phase 4Recruiting
- Sponsor
- Guilin Maternal and Child Health Care Hospital
- Start
- May 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of erythropoietin in anemia of prematurity (AOP) (3 arms), sponsored by Guilin Maternal and Child Health Care Hospital. Primary endpoints: Retinal screening in prematurity, hemoglobin and 3 more. Started May 2019; status: recruiting.
02
Drugs
erythropoietin
03
Conditions
anemia of prematurity (AOP)
Beyond the preview
Go deeper on ChiCTR2100042351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042351.